Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:00:23.869Z.
Calculation as of: 2026-10-06T19:00:23.869Z.
Quote observation: 2026-10-06T18:59:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca6b3f945453907090b614e1109f6f6fce8b12406cb587c45253d0481e46e17d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$33.11M
EV/EBITDA Ratio
N/A
TTM Avg
25.79x
3Y Avg
51.85x
5Y Avg
38.84x
Market Cap
$31.86M
EV/EBITDA Ratio
N/A
TTM Avg
26.23x
3Y Avg
26.23x
5Y Avg
26.23x
Market Cap
$31.50M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.44M
EV/EBITDA Ratio
12.82x
TTM Avg
114.94x
3Y Avg
46.61x
5Y Avg
32.69x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.29M | N/A | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $33.29M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $33.11M | N/A | 25.79x | 51.85x | 38.84x |
| HeartBeam, Inc. (BEAT)vs › | $34.05M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.70M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.86M | N/A | 26.23x | 26.23x | 26.23x |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.50M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 12.82x | 114.94x | 46.61x | 32.69x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
